ROCKETDNA LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.007 AUD | -22.22% |
|
-12.50% | -12.50% |
| Apr. 16 | Transcript : RocketDNA Ltd. - Special Call | |
| Apr. 10 | RocketDNA Launches First Batch of New XBot Drone Solution | MT |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Capitalization 1 | 21.53 | 11.77 | 4.604 | 5.218 |
| Enterprise Value (EV) 1 | 17.11 | 11.4 | 2.678 | 4.016 |
| P/E ratio | -33.7 x | -3.21 x | -2.39 x | -2.35 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 6.39 x | 2.57 x | 0.8 x | 0.85 x |
| EV / Revenue | 5.08 x | 2.49 x | 0.47 x | 0.65 x |
| EV / EBITDA | 50.2 x | -14.3 x | -1.62 x | -4.35 x |
| EV / FCF | 87,396,524 x | -37,893,224 x | 1,006,282 x | -12,600,813 x |
| FCF Yield | 0% | -0% | 0% | -0% |
| Price to Book | 1.89 x | 1.46 x | 0.82 x | 1.06 x |
| Nbr of stocks (in thousands) | 500,801 | 511,605 | 511,605 | 652,226 |
| Reference price 2 | 0.0430 | 0.0230 | 0.009000 | 0.008000 |
| Announcement Date | 3/31/21 | 3/31/22 | 2/26/23 | 2/27/24 |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Net sales 1 | 3.525 | 3.369 | 4.582 | 5.735 | 6.137 |
| EBITDA 1 | 0.5289 | 0.3408 | -0.796 | -1.652 | -0.9241 |
| EBIT 1 | 0.00342 | -0.121 | -1.766 | -2.385 | -1.672 |
| Operating Margin | 0.1% | -3.59% | -38.54% | -41.59% | -27.25% |
| Earnings before Tax (EBT) 1 | 0.1659 | -0.0289 | -1.744 | -2.335 | -1.793 |
| Net income 1 | 0.1283 | -0.184 | -3.618 | -1.923 | -1.769 |
| Net margin | 3.64% | -5.46% | -78.96% | -33.54% | -28.83% |
| EPS 2 | 0.000945 | -0.001275 | -0.007163 | -0.003759 | -0.003400 |
| Free Cash Flow | - | 0.1957 | -0.3008 | 2.662 | -0.3187 |
| FCF margin | - | 5.81% | -6.57% | 46.41% | -5.19% |
| FCF Conversion (EBITDA) | - | 57.44% | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 3/31/21 | 3/31/21 | 3/31/22 | 2/26/23 | 2/27/24 |
1AUD in Million2AUD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Net Debt 1 | 2.78 | - | - | - | - |
| Net Cash position 1 | - | 4.43 | 0.37 | 1.93 | 1.2 |
| Leverage (Debt/EBITDA) | 5.254 x | - | - | - | - |
| Free Cash Flow | - | 0.2 | -0.3 | 2.66 | -0.32 |
| ROE (net income / shareholders' equity) | - | -2.13% | -17.4% | -35.1% | -36.2% |
| ROA (Net income/ Total Assets) | - | -0.87% | -8.6% | -16.3% | -15.2% |
| Assets 1 | - | 21.22 | 42.07 | 11.8 | 11.67 |
| Book Value Per Share 2 | -0 | 0.0200 | 0.0200 | 0.0100 | 0.0100 |
| Cash Flow per Share 2 | 0.0100 | 0.0100 | 0 | 0 | 0 |
| Capex 1 | 0.31 | 0.36 | 0.81 | 0.8 | 0.69 |
| Capex / Sales | 8.85% | 10.66% | 17.77% | 13.87% | 11.24% |
| Announcement Date | 3/31/21 | 3/31/21 | 3/31/22 | 2/26/23 | 2/27/24 |
1AUD in Million2AUD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -12.50% | 3M | |
| -9.41% | 2.3B | |
| -22.78% | 599M | |
| -17.24% | 353M | |
| +57.95% | 103M |
- Stock Market
- Equities
- RKT Stock
- Financials RocketDNA Ltd.
